Improving Neurodevelopmental Surveillance and Follow-up in Infants with Congenital Heart Disease

Mark Michael1,2, Rebecca Scharf3, Lisa Letzkus3

  • 1Pediatric Cardiology, University of Virginia, Charlottesville, Va, USA.

Congenital Heart Disease
|February 23, 2016
PubMed

Insights

Implementing a neurodevelopmental surveillance protocol during cardiac surgery hospitalizations significantly improved patient assessment and follow-up rates for infants with congenital heart disease. This approach enhances care for high-risk children.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics
  • Health Services Research

Background:

  • Infants with congenital heart disease (CHD) are at increased risk for neurodevelopmental delays.
  • Early neurodevelopmental surveillance and timely follow-up are crucial for managing these risks.
  • Current surveillance and follow-up rates for at-risk infants with CHD are often suboptimal.

Purpose of the Study:

  • To evaluate the effectiveness of a novel protocol for neurodevelopmental surveillance during hospitalization for cardiac surgery in infants under 12 months.
  • To assess the impact of this protocol on neurodevelopmental assessment rates and outpatient follow-up compliance.
  • To identify patient factors influencing successful screening and follow-up.

Main Methods:

  • A protocol was implemented to increase neurodevelopmental surveillance for targeted high-risk infants during their cardiac surgery admission.
  • A historical control group from a preceding 6-month period was used for comparison.
  • Univariate analysis examined the influence of patient demographics, cardiac anatomy, hospital course, and travel distance on surveillance and follow-up outcomes.

Main Results:

  • Neurodevelopmental surveillance rates increased significantly from 21% to 82% post-protocol implementation (P < .001).
  • Outpatient follow-up compliance also improved, rising from 38% to 52% (P < .001).
  • Younger patients, those with longer intensive care unit and total hospital stays, and those with biventricular hearts were more likely to complete follow-up. Single ventricle anatomy was associated with lower follow-up rates.

Conclusions:

  • The implemented protocol effectively enhanced neurodevelopmental surveillance for high-risk infants with CHD.
  • Inpatient risk assessment facilitated better neurodevelopmental follow-up, particularly for younger patients and those with longer hospitalizations.
  • Modified follow-up schedules may be needed for patients with single ventricle anatomy to improve compliance, as travel distance was not a barrier.
Abstract

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.6K
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
329
Holter Monitor: 24-Hour Monitoring01:23

Holter Monitor: 24-Hour Monitoring

Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
4.2K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
405
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
365
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
503